Introduction
Recombinant Human GGPS1 Protein, also known as geranylgeranyl pyrophosphate synthase 1, is a key enzyme involved in the biosynthesis of isoprenoids. It is a 40 kDa protein that plays a crucial role in various biological processes, including cell proliferation, differentiation, and apoptosis. In this article, we will explore the structure, activity, and application of Recombinant Human GGPS1 Protein.
Structure of Recombinant Human GGPS1 Protein
Recombinant Human GGPS1 Protein is composed of 363 amino acids and is encoded by the GGPS1 gene located on chromosome 1q21.3. It belongs to the family of prenyltransferases and contains two domains: an N-terminal domain responsible for substrate binding and a C-terminal domain involved in catalytic activity.
The crystal structure of Recombinant Human GGPS1 Protein has been determined, revealing a homodimeric structure with each monomer containing 14 alpha-helices and 11 beta-strands. The active site of the enzyme is located at the interface of the two monomers, where the substrate geranylgeranyl diphosphate (GGPP) binds and undergoes a series of reactions to form geranylgeranyl pyrophosphate (GGPP).
Activity of Recombinant Human GGPS1 Protein
Recombinant Human GGPS1 Protein catalyzes the condensation of farnesyl diphosphate (FPP) and isopentenyl diphosphate (IPP) to form GGPP, which is a precursor for the biosynthesis of various isoprenoids, including cholesterol, ubiquinone, and dolichol. This reaction is essential for the post-translational modification of small GTP-binding proteins, such as Ras and Rho, which are involved in cell signaling pathways.
Recombinant Human GGPS1 Protein also plays a crucial role in the mevalonate pathway, which is responsible for the synthesis of cholesterol and other essential molecules. It is the first committed step in this pathway, and its activity is tightly regulated to maintain the balance of isoprenoid production in the cell.
Application of Recombinant Human GGPS1 Protein
Given its critical role in various biological processes, Recombinant Human GGPS1 Protein has been widely used in research and drug development. It is commonly used as an antigen in vaccine development to induce an immune response against isoprenoids, which have been implicated in various diseases, including cancer and cardiovascular diseases.
Recombinant Human GGPS1 Protein has also been studied as a potential drug target for cancer treatment. Inhibition of GGPS1 activity has been shown to induce cell death in cancer cells, making it a promising target for anti-cancer drugs. Additionally, GGPS1 inhibitors have been investigated for their potential to treat other diseases, such as malaria and osteoporosis.
Furthermore, Recombinant Human GGPS1 Protein has been used in the production of isoprenoids for commercial purposes. It is used to produce carotenoids, which are natural pigments with various applications in the food, cosmetic, and pharmaceutical industries. GGPS1 has also been used to produce coenzyme Q10, a vital antioxidant molecule with potential health benefits.
Conclusion
In summary, Recombinant Human GGPS1 Protein is a crucial enzyme involved in the biosynthesis of isoprenoids. Its structure and activity have been extensively studied, and it has various applications in research and drug development. With its potential as a drug target and its role in the production of essential molecules, Recombinant Human GGPS1 Protein continues to be an important focus of scientific research.
There are no reviews yet.